Clinical trial
Random Trial for Elderly Patients With NSCLC
NCT00265694 · Inje University, Other · Unknown status
Key facts
| NCT number | NCT00265694 |
|---|---|
| Title | Random Trial for Elderly Patients With NSCLC |
| Official title | A Randomized Phase III Trial of Vinorelbine Versus Gemcitabine and Carboplatin for Elderly Patients With Advanced Non-Small Cell Lung Cancer |
| Lead sponsor | Inje University, Other |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Non-Small Cell Lung Cancer |
| Intervention type | Drug |
| Interventions | vinorelbine, gemcitabine and carboplatin |
| First posted | Dec 15, 2005 |
| Last update posted | Dec 15, 2005 |
| Countries | South Korea |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: